Lnc2Cancer

Experimentally Supported Human LncRNA and Cancer Associations Database

LncRNA centric

Cancer centric

Advanced search

Drug resistant

Circulating

Prognosis

Detail


   LncRNA Name HOXB-AS3
   Synonyms HOXA6as
   Region GRCh38_7:27129977-27155928    Sequence
   Ensembl ENSG00000254369
   RefSeq NR_038831
   Circulating
   Drug-resisitant
   Prognostic
   MiRNA
   Variant
   TF
   Methylation
   Cancer Name colon cancer
   ICD-0-3 C18  
   Methods qPCR, Western blot etc.
   Sample cell lines (SW480, SW620, HTC-116, MDA-MB-231, SK-OV-3, S18, S26, HEK293T)
   Expression Pattern down-regulated
   Function Description

Here, we discovered that the lncRNA HOXB-AS3 encodes a conserved 53-aa peptide. The HOXB-AS3 peptide, not lncRNA, suppresses colon cancer (CRC) growth. Mechanistically, the HOXB-AS3 peptide competitively binds to the ariginine residues in RGG motif of hnRNP A1 and antagonizes the hnRNP A1-mediated regulation of pyruvate kinase M (PKM) splicing by blocking the binding of the ariginine residues in RGG motif of hnRNP A1 to the sequences flanking PKM exon 9, ensuring the formation of lower PKM2 and suppressing glucose metabolism reprogramming. CRC patients with low levels of HOXB-AS3 peptide have poorer prognoses. Our study indicates that the loss of HOXB-AS3 peptide is a critical oncogenic event in CRC metabolic reprogramming.

   Pubmed ID 28985503
   Year 2017
   Title A Peptide Encoded by a Putative lncRNA HOXB-AS3 Suppresses Colon Cancer Growth
   External Links
   Links for  HOXB-AS3 GenBank       HGNC       lncrnadb       Noncode
   Links for  colon cancer Omim       Cosmic

CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.